Merck, Plaintiffs Bicker Over Fosamax MDL Wind-Down Plans

Law360, New York (August 19, 2013, 7:56 PM EDT) -- Merck & Co. Inc. and the plaintiffs suing the company over jaw injuries allegedly caused by the bone drug Fosamax proposed competing plans for the wind-down of multidistrict litigation on Monday, with the drugmaker claiming its opponents seek to “dump” the cases across the country.

Merck and the plaintiffs' steering committee sent a joint letter to U.S. District Judge John Keenan outlining their proposals for the transfer of the remaining cases in the litigation, as the judge requested during a status conference last week. He said...
To view the full article, register now.